Components of Mechanical Power on the Functional Lung in ARDS

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRamos Mejía Hospital

About this trial

Mechanical power (MP) is a composite variable that integrates static and dynamic respiratory parameters and has been associated with ventilator-induced lung injury (VILI). MP is predominantly delivered to the reduced functional lung size, commonly referred to as the "baby lung" (BL). Functional lung size, in turn, is closely related to respiratory system compliance (Crs). Previous studies have demonstrated an association between MP normalized to compliance (MP/Crs) and mortality. Moreover, evidence suggests that VILI associated with MP/Crs results primarily from the combined effect of its components rather than from any single component in isolation.

The objective of this study is to evaluate both the overall and the relative contribution of each component of mechanical power, normalized to compliance (MP/Crs), to in-hospital mortality in patients with acute respiratory distress syndrome (ARDS).

Eligibility criteria

Qualifiers

Patients ≥ 18 years

Diagnosis of acute respiratory distress syndrome

Receiving invasive mechanical ventilation (volume control mode) for at least 48 consecutive hours.

Disqualifiers

Patients spontaneously breathing

Patients under non-invasive support therapies

Patients receiving ventilation through a tracheostomy cannula at any time during the first 48 h

Patients that receiving pressure-controlled ventilation or any modality other than volume-controlled

Trial design

Treatments tested in this trial

  • monitoring of clinical and ventilatory variables

Treatment groups

184 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Ramos Mejía Hospital

Lead sponsor

Universidad de la Republica

Collaborator